Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Damon Runyon Cancer Research Foundation Awards $2.7M To 7 Top Young Clinical Investigators
The Damon Runyon Cancer Research Foundation named 4 new Damon Runyon Clinical Investigators at its April 2009 Clinical Investigator Award Committee review. The recipients of this prestigious, three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation"s leading scientists and clinicians. Each will receive $450,000 to support the development of his cancer research program.

Gefitinib Receives European Licence For The Treatment Of Lung Cancer For Patients With EGFR Activating Mutation Positive Tumours
AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine kinase) activating mutation positive patients with Non Small Cell Lung Cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for 80% of all lung cancer cases. [1] The licence means that for the first time, thousands [2] of patients undergoing first line treatment of NSCLC in the UK may benefit from a more effective, [3] oral alternative to doublet chemotherapy (UK standard of care) without many of the side effects associated with chemotherapy. [3]
News of the day
In Elderly Lung Cancer Patients, All-Biologic Regimen Found To Be Efficacious And Well-Tolerated
Previously untreated non-small cell lung cancer (NSCLC) patients over the age of 70 respond well to a combination of bevacizumab and erlotinib, Fox Chase Cancer Center researchers reported at the annual meeting of the International Association for the Study of Lung Cancer.
Oncology

Minorities, Poor Find Communicating With Doctors More Difficult

Patient-provider communication influences quality of care, but black and Asian patients were more likely than white patients to report communication difficulties with their doctors in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Good communication is important for the medical care provider to understand the patient"s needs, wants, and preferences, and for the patient to understand and participate in his or her own care. AHRQ found that roughly 13 percent of blacks and Asians reported communication problems with their doctors in 2005, compared with 9 percent of whites. Moreover, the gap between blacks and whites widened between 2002 and 2005. In contrast, the gap between Hispanic and non-Hispanic white adults narrowed . Even so, about 12 percent of Hispanic adults reported difficulties communicating with their doctors in 2005. The federal agency"s analysis also showed that: - Roughly twice as many poor people as high-income people, regardless of their race or ethnicity, reported communication problems in 2005 (15 percent vs. 7 percent). - Among high school graduates, blacks (13 percent) were more likely that whites (9 percent), and Hispanics (12 percent) were more likely than whites (8.5 percent) to report poor communication with their health providers. - Among people with less than a high school education, blacks were more likely than whites to report communication problems (18.6 percent and 12.5 percent respectively). This AHRQ News and Numbers summary is based on data from the 2008 National Healthcare Disparities Report , which examines the disparities in Americans" access to and quality of health care, with breakdowns by race, ethnicity, income, and education. Agency for Healthcare Research and Quality


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009